Oral 24-week probiotics supplementation did not decrease cardiovascular risk markers in patients with biopsy proven NASH: A double-blind placebo-controlled randomized study Samantha Thifani Alrutz Barcelos; Amanda Souza Silva-Sperb; Helena Abadie Moraes; Larisse Longo; Bruna Concheski de Moura; Matheus Truccolo Michalczuk; Carolina Uribe-Cruz; Carlos Thadeu Schmidt Cerski; Themis Reverbel da Silveira; Valesca Dall'Alba; Mário Reis Álvares-da-Silva;

STAT3: A key regulator in liver fibrosis Jie Zhao; Yong-Fen Qi; Yan-Rong Yu;

Societal costs and survival of patients with biopsy-verified non-alcoholic steatohepatitis: Danish nationwide register-based study Jan Håkon Rudolfsen; Lise Lotte Gluud; Henning Grønbæk; Majken K. Jensen; Mogens Vyberg; Jens Olsen; Peter Bo Poulsen; Nanna Hovelsø; Nikolaj Ture Gregersen; Anne Bloch Thomsen; Peter Jepsen;